Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 14 04:00PM ET
7.99
Dollar change
-0.18
Percentage change
-2.20
%
IndexRUT P/E- EPS (ttm)-1.32 Insider Own8.86% Shs Outstand160.42M Perf Week-4.20%
Market Cap1.29B Forward P/E14.66 EPS next Y0.55 Insider Trans-0.10% Shs Float146.60M Perf Month2.04%
Income-187.50M PEG- EPS next Q-0.43 Inst Own59.80% Short Float26.76% Perf Quarter-8.89%
Sales682.16M P/S1.88 EPS this Y81.77% Inst Trans1.97% Short Ratio9.13 Perf Half Y-34.99%
Book/sh-3.89 P/B- EPS next Y342.99% ROA-10.84% Short Interest39.23M Perf Year57.91%
Cash/sh5.81 P/C1.38 EPS next 5Y67.92% ROE- 52W Range3.81 - 23.86 Perf YTD-0.62%
Dividend Est.- P/FCF- EPS past 5Y25.88% ROI- 52W High-66.51% Beta2.99
Dividend TTM- Quick Ratio0.97 Sales past 5Y516.28% Gross Margin71.28% 52W Low109.71% ATR (14)0.57
Dividend Ex-DateDec 13, 2007 Current Ratio0.98 EPS Y/Y TTM77.62% Oper. Margin-34.00% RSI (14)48.73 Volatility6.33% 7.73%
Employees952 Debt/Eq- Sales Y/Y TTM-30.65% Profit Margin-27.49% Recom2.14 Target Price16.43
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q64.94% Payout- Rel Volume1.16 Prev Close8.17
Sales Surprise4.66% EPS Surprise0.78% Sales Q/Q-69.69% EarningsFeb 27 BMO Avg Volume4.29M Price7.99
SMA201.35% SMA50-5.14% SMA200-27.78% Trades Volume4,999,427 Change-2.20%
Date Action Analyst Rating Change Price Target Change
Feb-28-25Initiated BTIG Research Buy $19
Jul-30-24Downgrade JP Morgan Neutral → Underweight $8
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Mar-15-25 07:15AM
Mar-11-25 08:00AM
Mar-08-25 11:21AM
Mar-04-25 09:00AM
Feb-28-25 08:00AM
02:11AM Loading…
02:11AM
Feb-27-25 04:05PM
12:21PM
11:30AM
11:24AM
09:46AM
09:25AM
09:15AM
08:18AM
08:06AM
08:05AM Loading…
08:05AM
08:00AM
Feb-20-25 05:45PM
09:00AM
08:00AM
Feb-10-25 05:45PM
Feb-04-25 05:45PM
11:55AM
09:00AM
Jan-27-25 05:45PM
Jan-24-25 04:14PM
Jan-22-25 09:55AM
09:00AM
Jan-20-25 10:04PM
Jan-17-25 01:55PM
05:45PM Loading…
Jan-15-25 05:45PM
Jan-08-25 04:03PM
09:13AM
09:13AM
09:00AM
06:09AM
Jan-07-25 04:12PM
11:26AM
Dec-24-24 09:00AM
Dec-13-24 09:59AM
08:00AM
Dec-12-24 11:30AM
04:34AM
Dec-10-24 09:00AM
08:00AM
Dec-09-24 08:08PM
Dec-05-24 05:30AM
Dec-04-24 06:07AM
03:03AM
02:00AM
Nov-29-24 09:00AM
Nov-21-24 03:35PM
Nov-18-24 09:00AM
Nov-15-24 04:19PM
12:04PM
12:04PM
10:46AM
07:47AM
05:21AM
02:08AM
Nov-14-24 04:28PM
Nov-13-24 08:00AM
02:08AM
Nov-12-24 02:43PM
02:43PM
12:52PM
10:33AM
09:48AM
09:44AM
09:20AM
08:13AM
08:05AM
08:02AM
Nov-11-24 12:49PM
09:07AM
08:58AM
08:30AM
06:53AM
Nov-08-24 01:02PM
Nov-06-24 01:13PM
Nov-05-24 10:00AM
Nov-04-24 04:30PM
06:00AM
Nov-01-24 09:00AM
Oct-29-24 05:45PM
Oct-26-24 12:29PM
12:29PM
Oct-23-24 05:45PM
Oct-22-24 04:00AM
Oct-21-24 09:00AM
07:45AM
Oct-19-24 06:15PM
Oct-17-24 05:45PM
10:07AM
08:18AM
07:08AM
Oct-16-24 04:34PM
03:50PM
01:20PM
11:58AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trizzino JohnPresident and COOMar 07 '25Option Exercise0.0028,890082,015Mar 11 04:34 PM
Kelly James PatrickEVP, CFO and TreasurerMar 07 '25Option Exercise0.0012,223075,155Mar 11 04:33 PM
Trizzino JohnPresident and COOMar 01 '25Option Exercise0.0048,000076,310Mar 04 06:47 PM
Casey Mark JEVP, Chief Legal OfficerMar 01 '25Option Exercise0.004,000033,187Mar 04 06:46 PM
Kelly James PatrickEVP, CFO and TreasurerMar 01 '25Option Exercise0.0058,667091,269Mar 04 06:43 PM
Jacobs John CPresident and CEOMar 01 '25Option Exercise0.0083,3340175,183Mar 04 06:42 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '25Option Exercise0.0059,600073,825Mar 04 06:39 PM
Jacobs John CPresident and CEOJan 23 '25Option Exercise0.0083,1960130,722Jan 27 06:19 PM
Kelly James PatrickEVP, CFO and TreasurerDec 31 '24Option Exercise0.0035,000049,508Jan 03 05:41 PM
Rodgers Richard JDirectorOct 29 '24Option Exercise0.003,800014,270Jan 02 04:52 PM
King Rachel K.DirectorDec 13 '24Sale9.024,15037,43514,770Jan 02 04:47 PM
YOUNG JAMES FDirectorDec 31 '24Sale8.005,40043,20051,760Jan 02 04:44 PM
YOUNG JAMES FDirectorDec 24 '24Sale8.484,60039,00857,160Jan 02 04:44 PM
YOUNG JAMES FDirectorDec 24 '24Proposed Sale8.4810,00084,800Dec 26 10:31 AM
Casey Mark JEVP, Chief Legal OfficerDec 11 '24Option Exercise0.0041,900041,900Dec 13 05:24 PM
Rachel K. KingBoard MemberDec 13 '24Proposed Sale9.004,15037,350Dec 13 12:13 PM
Dubovsky FilipOfficerSep 18 '24Proposed Sale13.007,33595,331Sep 18 04:08 PM
Trizzino JohnEVP, CCO and CBOAug 19 '24Option Exercise0.00655028,627Aug 21 04:47 PM
Kelly James PatrickEVP, CFO and TreasurerAug 16 '24Option Exercise12.962,36730,67615,652Aug 20 05:06 PM
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM